EVH Evolent Health Inc
Price (delayed)
$10.43
Market cap
$1.22B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.81
Enterprise value
$1.83B
Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care
Highlights
Evolent Health's net income has increased by 45% YoY and by 23% QoQ
The EPS rose by 37% YoY and by 12% QoQ
The gross margin has contracted by 38% YoY and by 10% from the previous quarter
EVH's gross profit is down by 20% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of EVH
Market
Valuations
Earnings
Shares outstanding
116.59M
Market cap
$1.22B
Enterprise value
$1.83B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.21
Price to sales (P/S)
0.47
EV/EBIT
N/A
EV/EBITDA
22.8
EV/Sales
0.71
Revenue
$2.55B
Gross profit
$367.35M
Operating income
-$35.58M
Net income
-$61.62M
EBIT
-$38.31M
EBITDA
$80.06M
Free cash flow
-$6.13M
Per share
Balance sheet
Liquidity
EPS
-$0.81
EPS diluted
-$0.81
Free cash flow per share
-$0.05
Book value per share
$8.59
Revenue per share
$22.28
TBVPS
$6.34
Total assets
$2.54B
Total liabilities
$1.35B
Debt
$713.67M
Equity
$1B
Working capital
-$108.38M
Debt to equity
0.71
Current ratio
0.85
Quick ratio
0.81
Net debt/EBITDA
7.61
Margins
Efficiency
Dividend
EBITDA margin
3.1%
Gross margin
14.4%
Net margin
-2.4%
Operating margin
-1.4%
Return on assets
-3.7%
Return on equity
-8.6%
Return on invested capital
-5.9%
Return on capital employed
-2.1%
Return on sales
-1.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EVH stock price
How has the Evolent Health stock price performed over time
Intraday
-2.61%
1 week
4.09%
1 month
2.56%
1 year
-65.16%
YTD
-7.29%
QTD
-7.29%
Financial performance
How have Evolent Health's revenue and profit performed over time
Revenue
$2.55B
Gross profit
$367.35M
Operating income
-$35.58M
Net income
-$61.62M
Gross margin
14.4%
Net margin
-2.4%
The net margin has soared by 59% YoY and by 27% QoQ
The operating margin has increased by 48% YoY but it has decreased by 27% from the previous quarter
Evolent Health's net income has increased by 45% YoY and by 23% QoQ
The gross margin has contracted by 38% YoY and by 10% from the previous quarter
Growth
What is Evolent Health's growth rate over time
Valuation
What is Evolent Health stock price valuation
P/E
N/A
P/B
1.21
P/S
0.47
EV/EBIT
N/A
EV/EBITDA
22.8
EV/Sales
0.71
The EPS rose by 37% YoY and by 12% QoQ
EVH's price to book (P/B) is 58% lower than its 5-year quarterly average of 2.9 and 50% lower than its last 4 quarters average of 2.4
The company's equity fell by 6% YoY and by 3.6% QoQ
The price to sales (P/S) is 74% lower than the 5-year quarterly average of 1.8 and 57% lower than the last 4 quarters average of 1.1
The revenue has grown by 30% YoY and by 3.7% from the previous quarter
Efficiency
How efficient is Evolent Health business performance
The ROS has soared by 80% YoY and by 42% QoQ
EVH's return on invested capital has surged by 73% year-on-year and by 41% since the previous quarter
The ROE has grown by 34% YoY and by 9% from the previous quarter
Evolent Health's return on assets has increased by 31% YoY and by 8% QoQ
Dividends
What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EVH.
Financial health
How did Evolent Health financials performed over time
The company's total assets is 88% higher than its total liabilities
The quick ratio has contracted by 18% from the previous quarter and by 16% YoY
The company's current ratio fell by 18% QoQ and by 16% YoY
The debt is 29% lower than the equity
EVH's debt to equity is up by 18% year-on-year and by 16% since the previous quarter
The debt has increased by 12% QoQ and by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.